PL397623A1 - Preparat poprawiajacy pamiec oraz uczenie sie, sposób jego wytwarzania, srodek farmaceutyczny, dodatek zywieniowy oraz jego zastosowanie - Google Patents

Preparat poprawiajacy pamiec oraz uczenie sie, sposób jego wytwarzania, srodek farmaceutyczny, dodatek zywieniowy oraz jego zastosowanie

Info

Publication number
PL397623A1
PL397623A1 PL397623A PL39762311A PL397623A1 PL 397623 A1 PL397623 A1 PL 397623A1 PL 397623 A PL397623 A PL 397623A PL 39762311 A PL39762311 A PL 39762311A PL 397623 A1 PL397623 A1 PL 397623A1
Authority
PL
Poland
Prior art keywords
learning
preparation
nutritional supplement
pharmaceutical
manufacture
Prior art date
Application number
PL397623A
Other languages
English (en)
Inventor
Bogdan Lang
Andrzej W. Lipkowski
Mariusz Sacharczuk
Elżbieta Salińska
Original Assignee
Napco S. Ar.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Napco S. Ar.L. filed Critical Napco S. Ar.L.
Priority to PL397623A priority Critical patent/PL397623A1/pl
Priority to EP12818900.8A priority patent/EP2797618A1/en
Priority to US14/369,246 priority patent/US20150018282A1/en
Priority to PCT/EP2012/077100 priority patent/WO2013098415A1/en
Publication of PL397623A1 publication Critical patent/PL397623A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)

Abstract

Ujawniono preparat poprawiajacy pamiec oraz uczenie sie, który zawiera enzymatyczny hydrolizat bialek zwierzecej tkanki ukladu nerwowego. Wspomniana tkanke stanowi rdzen kregowy zwierzat rzeznych, zas bialkiem jest bialko mielinowe. Wynalazek dotyczy równiez sposobu wytwarzania preparatu poprawiajacego pamiec oraz uczenie sie i produktu leczniczego a takze dodatku zywieniowego zawierajacego wymieniony enzymatyczny hydrolizat bialek. Ponadto przedmiotem wynalazku jest zastosowanie hydrolizatu bialek zwierzecej tkanki ukladu nerwowego.
PL397623A 2011-12-30 2011-12-30 Preparat poprawiajacy pamiec oraz uczenie sie, sposób jego wytwarzania, srodek farmaceutyczny, dodatek zywieniowy oraz jego zastosowanie PL397623A1 (pl)

Priority Applications (4)

Application Number Priority Date Filing Date Title
PL397623A PL397623A1 (pl) 2011-12-30 2011-12-30 Preparat poprawiajacy pamiec oraz uczenie sie, sposób jego wytwarzania, srodek farmaceutyczny, dodatek zywieniowy oraz jego zastosowanie
EP12818900.8A EP2797618A1 (en) 2011-12-30 2012-12-29 Preparation for improving memory and learning and use thereof
US14/369,246 US20150018282A1 (en) 2011-12-30 2012-12-29 Preparation for improving memory and learning and use thereof
PCT/EP2012/077100 WO2013098415A1 (en) 2011-12-30 2012-12-29 Preparation for improving memory and learning and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL397623A PL397623A1 (pl) 2011-12-30 2011-12-30 Preparat poprawiajacy pamiec oraz uczenie sie, sposób jego wytwarzania, srodek farmaceutyczny, dodatek zywieniowy oraz jego zastosowanie

Publications (1)

Publication Number Publication Date
PL397623A1 true PL397623A1 (pl) 2013-07-08

Family

ID=47605455

Family Applications (1)

Application Number Title Priority Date Filing Date
PL397623A PL397623A1 (pl) 2011-12-30 2011-12-30 Preparat poprawiajacy pamiec oraz uczenie sie, sposób jego wytwarzania, srodek farmaceutyczny, dodatek zywieniowy oraz jego zastosowanie

Country Status (4)

Country Link
US (1) US20150018282A1 (pl)
EP (1) EP2797618A1 (pl)
PL (1) PL397623A1 (pl)
WO (1) WO2013098415A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3397078A1 (en) 2015-12-28 2018-11-07 Abbott Laboratories Nutritional compositions comprising hydrolyzed protein and a modified fat system and uses thereof
JP7466886B2 (ja) * 2019-06-21 2024-04-15 学校法人帝京大学 孵化後の鳥類ヒナの学習特性を利用した認知機能向上薬のスクリーニング方法
CN116172205B (zh) * 2022-11-18 2025-01-07 黑龙江飞鹤乳业有限公司 碱性蛋白的用途，包括其的营养组合物、功能性食品及用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1276494A4 (en) 2000-04-20 2005-02-09 Todd C Sacktor PROTEIN ENHANCES MEMORY
CN102764425B (zh) * 2000-08-21 2015-11-25 阿皮托普技术(布里斯托尔)有限公司 肽选择方法
JPWO2004047875A1 (ja) 2002-11-27 2006-03-23 財団法人半導体研究振興会 電磁波照射装置
WO2006019804A2 (en) * 2004-07-14 2006-02-23 Wyeth Compositions and methods of purifying myelin-associated glycoprotein (mag)
US8008259B2 (en) * 2005-11-07 2011-08-30 Copenhagen University, Techtrans Unit Neurotrophin-derived peptide sequences
US20100081613A1 (en) 2006-10-11 2010-04-01 The Trustees Of Columbia University In The City Of New York Methods and compositions for enhancing memory
US20100093646A1 (en) 2006-10-23 2010-04-15 Kyowa Hakko Bio Co., Ltd. Method for enhancing memory in normal individual
KR101063330B1 (ko) 2008-10-14 2011-09-07 서울대학교산학협력단 단백질을 유효성분으로 함유하는 기억력 증진용 약학 조성물
WO2011047204A1 (en) 2009-10-14 2011-04-21 Mount Sinai School Of Medicine Method of treating memory disorders and enhancing memory using igf-ii compounds

Also Published As

Publication number Publication date
US20150018282A1 (en) 2015-01-15
WO2013098415A1 (en) 2013-07-04
EP2797618A1 (en) 2014-11-05

Similar Documents

Publication Publication Date Title
ZA202004764B (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
MY182593A (en) Composition containing chitin and digestible proteins
MX385015B (es) Suplemento alimenticio.
EP4275760A3 (en) Egg protein formulations and methods of manufacture thereof
EA201300669A1 (ru) Замещенные 1-бензилциклоалкилкарбоновые кислоты и их применение
BR112012032008A2 (pt) anticorpos s100a4 e usos terapêuticos do mesmo
BR112014007741A2 (pt) bebidas nutritivas
BR112015024757A2 (pt) métodos para aprimorar síntese de proteína muscular seguindo treinamento simultâneo
MX2021013880A (es) Polimeros enlazados al proton para administracion oral.
NI201400069A (es) Proceso para aislamiento de una composición de proteína y una composición de grasa a partir de aves de corral deshuesadas mecánicamente.
BR112016024911A2 (pt) composições de proteínas solúveis e métodos de sua produçâo
BR112015001227A2 (pt) métodos de produção de hidrolisato de queratina, de degradação de queratina e de produção de ração animal, usos de uma composição e de hidrolisato de queratina, hidrolisato de queratina, composição de aditivo alimentar, alimento e produto.
MX382077B (es) Polimeros de union a protones para administracion oral.
EA023877B9 (ru) Макет головы для медицинской подготовки хирургов и способ
BR112013026447A2 (pt) métodos para a regulação da expressão de gene de sirtuína
TW201613631A (en) Ghrelin secretion promoter
EA201300175A1 (ru) Таблетка с контролируемым трехфазным высвобождением, содержащая мелатонин, и способ ее изготовления
MX2021012080A (es) Composicion, formulas probioticas y metodos para favorecer la digestion y mejorar la nutricion en la apicultura.
PL397623A1 (pl) Preparat poprawiajacy pamiec oraz uczenie sie, sposób jego wytwarzania, srodek farmaceutyczny, dodatek zywieniowy oraz jego zastosowanie
CL2013001841A1 (es) Reactor de membrana para la fabricacion de hidrolizados de proteina vegetal; metodo para la fabricacion de hidrolizados de proteina vegetal; e hidrolizado de proteina vegetal.
EA201390867A1 (ru) Композиции на основе глины и обножки, способ их получения и их применение в питании и терапевтическом лечении
EA201270176A1 (ru) Производные тазаротена
CR20130577A (es) Producto de proteínas y proceso para la fabricación de un producto de proteínas a partir de exudado de carne cruda
EA201391742A1 (ru) Фармацевтическая композиция, включающая фексофенадин
BR112017025481A2 (pt) hidrolisado de proteína e uso do mesmo, ração animal ou suplemento de animal de estimação ou produto farmacêutico de animal de estimação tendo palatabilidade melhorada, método de preparação de uma ração animal, e, método para aumentar a palatabilidade de uma composição para consumo.